1
|
Obrecht M, Zurbruegg S, Accart N, Lambert C, Doelemeyer A, Ledermann B, Beckmann N. Magnetic resonance imaging and ultrasound elastography in the context of preclinical pharmacological research: significance for the 3R principles. Front Pharmacol 2023; 14:1177421. [PMID: 37448960 PMCID: PMC10337591 DOI: 10.3389/fphar.2023.1177421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Accepted: 06/16/2023] [Indexed: 07/18/2023] Open
Abstract
The 3Rs principles-reduction, refinement, replacement-are at the core of preclinical research within drug discovery, which still relies to a great extent on the availability of models of disease in animals. Minimizing their distress, reducing their number as well as searching for means to replace them in experimental studies are constant objectives in this area. Due to its non-invasive character in vivo imaging supports these efforts by enabling repeated longitudinal assessments in each animal which serves as its own control, thereby enabling to reduce considerably the animal utilization in the experiments. The repetitive monitoring of pathology progression and the effects of therapy becomes feasible by assessment of quantitative biomarkers. Moreover, imaging has translational prospects by facilitating the comparison of studies performed in small rodents and humans. Also, learnings from the clinic may be potentially back-translated to preclinical settings and therefore contribute to refining animal investigations. By concentrating on activities around the application of magnetic resonance imaging (MRI) and ultrasound elastography to small rodent models of disease, we aim to illustrate how in vivo imaging contributes primarily to reduction and refinement in the context of pharmacological research.
Collapse
Affiliation(s)
- Michael Obrecht
- Diseases of Aging and Regenerative Medicines, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Stefan Zurbruegg
- Neurosciences Department, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Nathalie Accart
- Diseases of Aging and Regenerative Medicines, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Christian Lambert
- Diseases of Aging and Regenerative Medicines, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Arno Doelemeyer
- Diseases of Aging and Regenerative Medicines, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Birgit Ledermann
- 3Rs Leader, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Nicolau Beckmann
- Diseases of Aging and Regenerative Medicines, Novartis Institutes for BioMedical Research, Basel, Switzerland
| |
Collapse
|
2
|
Bianchi A, Gobbo OL, Dufort S, Sancey L, Lux F, Tillement O, Coll JL, Crémillieux Y. Orotracheal manganese-enhanced MRI (MEMRI): An effective approach for lung tumor detection. NMR IN BIOMEDICINE 2017; 30:e3790. [PMID: 28857310 DOI: 10.1002/nbm.3790] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2016] [Revised: 07/15/2017] [Accepted: 07/19/2017] [Indexed: 06/07/2023]
Abstract
Lung cancer is a primary cause of cancer deaths worldwide. Timely detection of this pathology is necessary to delay or interrupt lung cancer progression, ultimately resulting in a possible better prognosis for the patient. In this context, magnetic resonance imaging (MRI) is especially promising. Ultra-short echo time (UTE) MRI sequences, in combination with gadolinium-based contrast agents, have indeed shown to be especially adapted to the detection of lung neoplastic lesions at submillimeter precision. Manganese-enhanced MRI (MEMRI) increasingly appears to be a possible effective alternative to gadolinium-enhanced MRI. In this work, we investigated whether low-dose MEMRI can effectively target non-small-cell lung cancer in rodents, whilst minimizing the potential toxic effect of manganese. Both systemic and orotracheal administration modalities allowed the identification of tumors of submillimeter size, as confirmed by bioluminescence imaging and histology. Equivalent tumor signal enhancements and contrast-to-noise ratios were observed with orotracheal administration using 20 times lower doses compared with the more conventional systemic route. This finding is of crucial importance as it supports the observation that higher performances of contrast agents can be obtained using an orotracheal administration route when targeting lung diseases. As a consequence, lower concentrations of contrast media can be employed, reducing the dose and potential safety issues. The non-detectable accumulation of ionic manganese in the brain and liver following orotracheal administration observed in vivo is extremely encouraging with regard to the safety of the orotracheal protocol with low-dose Mn2+ administration. To our knowledge, this is the first time that a study has clearly allowed the high-precision detection of lung tumor and its contours via the synergic employment of a strongly T1 -weighted MRI UTE sequence and ionic manganese, an inexpensive contrast agent. Overall, these results support the growing interest in drug and contrast agent delivery via the airways to target and diagnose several diseases of the lungs.
Collapse
Affiliation(s)
- Andrea Bianchi
- Centre de Résonance Magnétique des Systèmes Biologiques,CNRS UMR 5536, Université Bordeaux, Bordeaux, France
| | - Oliviero L Gobbo
- School of Pharmacy and Pharmaceutical Sciences and Institute of Neuroscience, Trinity College Dublin, Ireland
| | - Sandrine Dufort
- Nano-H S.A.S, Saint Quentin-Fallavier, France
- Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France
| | - Lucie Sancey
- Univ Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumiére Matiére, Lyon, France
| | - François Lux
- Univ Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumiére Matiére, Lyon, France
| | - Olivier Tillement
- Univ Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumiére Matiére, Lyon, France
| | - Jean-Luc Coll
- Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France
| | - Yannick Crémillieux
- Centre de Résonance Magnétique des Systèmes Biologiques,CNRS UMR 5536, Université Bordeaux, Bordeaux, France
| |
Collapse
|
3
|
Egger C, Cannet C, Gérard C, Suply T, Ksiazek I, Jarman E, Beckmann N. Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis. Eur J Pharmacol 2017; 809:64-72. [DOI: 10.1016/j.ejphar.2017.05.022] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Revised: 05/08/2017] [Accepted: 05/10/2017] [Indexed: 11/29/2022]
|
4
|
Fregonese L. Regulatory perspective on the use of lung imaging in drug development. IMAGING 2016. [DOI: 10.1183/2312508x.10003515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
5
|
Bianchi A, Tibiletti M, Kjørstad Å, Birk G, Schad LR, Stierstorfer B, Rasche V, Stiller D. Three-dimensional accurate detection of lung emphysema in rats using ultra-short and zero echo time MRI. NMR IN BIOMEDICINE 2015; 28:1471-1479. [PMID: 26403226 DOI: 10.1002/nbm.3417] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/06/2015] [Revised: 08/10/2015] [Accepted: 08/26/2015] [Indexed: 06/05/2023]
Abstract
Emphysema is a life-threatening pathology that causes irreversible destruction of alveolar walls. In vivo imaging techniques play a fundamental role in the early non-invasive pre-clinical and clinical detection and longitudinal follow-up of this pathology. In the present study, we aimed to evaluate the feasibility of using high resolution radial three-dimensional (3D) zero echo time (ZTE) and 3D ultra-short echo time (UTE) MRI to accurately detect lung pathomorphological changes in a rodent model of emphysema.Porcine pancreas elastase (PPE) was intratracheally administered to the rats to produce the emphysematous changes. 3D ZTE MRI, low and high definition 3D UTE MRI and micro-computed tomography images were acquired 4 weeks after the PPE challenge. Signal-to-noise ratios (SNRs) were measured in PPE-treated and control rats. T2* values were computed from low definition 3D UTE MRI. Histomorphometric measurements were made after euthanizing the animals. Both ZTE and UTE MR images showed a significant decrease in the SNR measured in PPE-treated lungs compared with controls, due to the pathomorphological changes taking place in the challenged lungs. A significant decrease in T2* values in PPE-challenged animals compared with controls was measured using UTE MRI. Histomorphometric measurements showed a significant increase in the mean linear intercept in PPE-treated lungs. UTE yielded significantly higher SNR compared with ZTE (14% and 30% higher in PPE-treated and non-PPE-treated lungs, respectively).This study showed that optimized 3D radial UTE and ZTE MRI can provide lung images of excellent quality, with high isotropic spatial resolution (400 µm) and SNR in parenchymal tissue (>25) and negligible motion artifacts in freely breathing animals. These techniques were shown to be useful non-invasive instruments to accurately and reliably detect the pathomorphological alterations taking place in emphysematous lungs, without incurring the risks of cumulative radiation exposure typical of micro-computed tomography.
Collapse
Affiliation(s)
- Andrea Bianchi
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, In-Vivo Imaging Laboratory, Biberach an der Riss, Germany
| | - Marta Tibiletti
- Core Facility Small Animal MRI, Ulm University, Ulm, Germany
| | - Åsmund Kjørstad
- Computer Assisted Clinical Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
- Department of Neuroradiology, University Hospital Hamburg-Eppendorf, Germany
| | - Gerald Birk
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, Target Validation Technologies, Biberach an der Riss, Germany
| | - Lothar R Schad
- Computer Assisted Clinical Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Birgit Stierstorfer
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, Target Validation Technologies, Biberach an der Riss, Germany
| | - Volker Rasche
- Core Facility Small Animal MRI, Ulm University, Ulm, Germany
- Department of Internal Medicine II, Ulm University, Ulm, Germany
| | - Detlef Stiller
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, In-Vivo Imaging Laboratory, Biberach an der Riss, Germany
| |
Collapse
|
6
|
Bianchi A, Moncelet D, Lux F, Plissonneau M, Rizzitelli S, Ribot EJ, Tassali N, Bouchaud V, Tillement O, Voisin P, Crémillieux Y. Orotracheal administration of contrast agents: a new protocol for brain tumor targeting. NMR IN BIOMEDICINE 2015; 28:738-746. [PMID: 25921808 DOI: 10.1002/nbm.3295] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/13/2014] [Revised: 02/17/2015] [Accepted: 03/07/2015] [Indexed: 06/04/2023]
Abstract
The development of new non-invasive diagnostic and therapeutic approaches is of paramount importance in order to improve the outcome of patients with glioblastoma (GBM). In this work we investigated a completely non-invasive pre-clinical protocol to effectively target and detect brain tumors through the orotracheal route, using ultra-small nanoparticles (USRPs) and MRI. A mouse model of GBM was developed. In vivo MRI acquisitions were performed before and after intravenous or orotracheal administration of the nanoparticles to identify and segment the tumor. The accumulation of the nanoparticles in neoplastic lesions was assessed ex vivo through fluorescence microscopy. Before the administration of contrast agents, MR images allowed the identification of the presence of abnormal brain tissue in 73% of animals. After orotracheal or intravenous administration of USRPs, in all the mice an excellent co-localization of the position of the tumor with MRI and histology was observed. The elimination time of the USRPs from the tumor after the orotracheal administration was approximately 70% longer compared with intravenous injection. MRI and USRPs were shown to be powerful imaging tools able to detect, quantify and longitudinally monitor the development of GBMs. The absence of ionizing radiation and high resolution of MRI, along with the complete non-invasiveness and good reproducibility of the proposed protocol, make this technique potentially translatable to humans. To our knowledge, this is the first time that the advantages of a needle-free orotracheal administration route have been demonstrated for the investigation of the pathomorphological changes due to GBMs.
Collapse
Affiliation(s)
- Andrea Bianchi
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Damien Moncelet
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - François Lux
- Institut Lumière Matière, CNRS UMR 5306, Université Claude Bernard, Domaine Scientifique de La Doua, Villeurbanne, France
| | - Marie Plissonneau
- Institut Lumière Matière, CNRS UMR 5306, Université Claude Bernard, Domaine Scientifique de La Doua, Villeurbanne, France
- Nano-H SAS, Saint-Quentin Fallavier, France
| | - Silvia Rizzitelli
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Emeline Julie Ribot
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Nawal Tassali
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Véronique Bouchaud
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Olivier Tillement
- Institut Lumière Matière, CNRS UMR 5306, Université Claude Bernard, Domaine Scientifique de La Doua, Villeurbanne, France
| | - Pierre Voisin
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Yannick Crémillieux
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| |
Collapse
|
7
|
Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents. Proc Natl Acad Sci U S A 2014; 111:9247-52. [PMID: 24927562 DOI: 10.1073/pnas.1402196111] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
One of the main reasons for the dismal prognosis of lung cancer is related to the late diagnosis of this pathology. In this work, we evaluated the potential of optimized lung MRI techniques and nebulized ultrasmall multimodal gadolinium-based contrast agents [ultrasmall rigid platforms (USRPs)] as a completely noninvasive approach for non-small-cell lung cancer (NSCLC) in vivo detection. A mouse model of NSCLC expressing the luciferase gene was developed. Ultrashort echo-time free-breathing MRI acquisitions were performed before and after i.v. or intrapulmonary administration of the nanoparticles to identify and segment the tumor. After orotracheal or i.v. administration of USRPs, an excellent colocalization of the position the tumor with MRI, bioluminescence and fluorescence reflectance imaging, and histology was observed in all mice. Significantly higher signal enhancements and contrast-to-noise ratios were observed with orotracheal administration using lower doses, reducing the toxicity issues and the interobserver variability in tumor detection. The observations suggested the existence of an unknown original mechanism (different from the enhanced permeability and retention effect) responsible for this phenomenon. MRI and USRPs were shown to be powerful imaging tools able to detect, quantify, and longitudinally monitor the development of submillimetric NSCLCs. The absence of ionizing radiation and high resolution MRI, along with the complete noninvasiveness and good reproducibility of the proposed protocol, make this technique potentially translatable to humans. To our knowledge this is the first time that the advantages of an orotracheal administration route are demonstrated for the investigation of the pathomorphological changes due to NSCLCs.
Collapse
|
8
|
Egger C, Gérard C, Vidotto N, Accart N, Cannet C, Dunbar A, Tigani B, Piaia A, Jarai G, Jarman E, Schmid HA, Beckmann N. Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230. Am J Physiol Lung Cell Mol Physiol 2014; 306:L1064-77. [PMID: 24727584 DOI: 10.1152/ajplung.00027.2014] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
Idiopathic pulmonary fibrosis is a progressive and lethal disease, characterized by loss of lung elasticity and alveolar surface area, secondary to alveolar epithelial cell injury, reactive inflammation, proliferation of fibroblasts, and deposition of extracellular matrix. The effects of oropharyngeal aspiration of bleomycin in Sprague-Dawley rats and C57BL/6 mice, as well as of intratracheal administration of ovalbumin to actively sensitized Brown Norway rats on total lung volume as assessed noninvasively by magnetic resonance imaging (MRI) were investigated here. Lung injury and volume were quantified by using nongated or respiratory-gated MRI acquisitions [ultrashort echo time (UTE) or gradient-echo techniques]. Lung function of bleomycin-challenged rats was examined additionally using a flexiVent system. Postmortem analyses included histology of collagen and hydroxyproline assays. Bleomycin induced an increase of MRI-assessed total lung volume, lung dry and wet weights, and hydroxyproline content as well as collagen amount. In bleomycin-treated rats, gated MRI showed an increased volume of the lung in the inspiratory and expiratory phases of the respiratory cycle and a temporary decrease of tidal volume. Decreased dynamic lung compliance was found in bleomycin-challenged rats. Bleomycin-induced increase of MRI-detected lung volume was consistent with tissue deposition during fibrotic processes resulting in decreased lung elasticity, whereas influences by edema or emphysema could be excluded. In ovalbumin-challenged rats, total lung volume quantified by MRI remained unchanged. The somatostatin analog, SOM230, was shown to have therapeutic effects on established bleomycin-induced fibrosis in rats. This work suggests MRI-detected total lung volume as readout for tissue-deposition in small rodent bleomycin models of pulmonary fibrosis.
Collapse
Affiliation(s)
- Christine Egger
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland; University of Basel, Biocenter, Basel, Switzerland
| | - Christelle Gérard
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Nella Vidotto
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Nathalie Accart
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Catherine Cannet
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Andrew Dunbar
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Bruno Tigani
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Alessandro Piaia
- Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland
| | - Gabor Jarai
- Novartis Institutes for BioMedical Research, Respiratory Diseases Department, Horsham, United Kingdom; and
| | - Elizabeth Jarman
- Novartis Institutes for BioMedical Research, Respiratory Diseases Department, Horsham, United Kingdom; and
| | - Herbert A Schmid
- Novartis Institutes for BioMedical Research, Oncology Department, Basel, Switzerland
| | - Nicolau Beckmann
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland;
| |
Collapse
|
9
|
Egger C, Cannet C, Gérard C, Jarman E, Jarai G, Feige A, Suply T, Micard A, Dunbar A, Tigani B, Beckmann N. Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology. PLoS One 2013; 8:e63432. [PMID: 23667616 PMCID: PMC3646779 DOI: 10.1371/journal.pone.0063432] [Citation(s) in RCA: 84] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2012] [Accepted: 04/04/2013] [Indexed: 02/07/2023] Open
Abstract
Pulmonary fibrosis can be experimentally induced in small rodents by bleomycin. The antibiotic is usually administered via the intratracheal or intranasal routes. In the present study, we investigated the oropharyngeal aspiration of bleomycin as an alternative route for the induction of lung fibrosis in rats and mice. The development of lung injury was followed in vivo by ultrashort echo time magnetic resonance imaging (UTE-MRI) and by post-mortem analyses (histology of collagen, hydroxyproline determination, and qRT-PCR). In C57BL/6 mice, oropharyngeal aspiration of bleomycin led to more prominent lung fibrosis as compared to intranasal administration. Consequently, the oropharyngeal aspiration route allowed a dose reduction of bleomycin and, therewith, a model refinement. Moreover, the distribution of collagen after oropharyngeal aspiration of bleomycin was more homogenous than after intranasal administration: for the oropharyngeal aspiration route, fibrotic areas appeared all over the lung lobes, while for the intranasal route fibrotic lesions appeared mainly around the largest superior airways. Thus, oropharyngeal aspiration of bleomycin induced morphological changes that were more comparable to the human disease than the intranasal administration route did. Oropharyngeal aspiration of bleomycin led to a homogeneous fibrotic injury also in rat lungs. The present data suggest oropharyngeal aspiration of bleomycin as a less invasive means to induce homogeneous and sustained fibrosis in the lungs of mice and rats.
Collapse
Affiliation(s)
- Christine Egger
- Global Imaging Group, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Biocenter, University of Basel, Basel, Switzerland
| | - Catherine Cannet
- Global Imaging Group, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Christelle Gérard
- Global Imaging Group, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Elizabeth Jarman
- Respiratory Diseases Department, Novartis Institutes for BioMedical Research, Horsham, United Kingdom
| | - Gabor Jarai
- Respiratory Diseases Department, Novartis Institutes for BioMedical Research, Horsham, United Kingdom
| | - Agnès Feige
- Developmental and Molecular Pathways Department, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Thomas Suply
- Developmental and Molecular Pathways Department, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Arthur Micard
- Global Imaging Group, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Andrew Dunbar
- Global Imaging Group, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Bruno Tigani
- Global Imaging Group, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Nicolau Beckmann
- Global Imaging Group, Novartis Institutes for BioMedical Research, Basel, Switzerland
- * E-mail:
| |
Collapse
|
10
|
Babin AL, Cannet C, Gérard C, Saint-Mezard P, Page CP, Sparrer H, Matsuguchi T, Beckmann N. Bleomycin-induced lung injury in mice investigated by MRI: model assessment for target analysis. Magn Reson Med 2011; 67:499-509. [PMID: 21656559 DOI: 10.1002/mrm.23009] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2011] [Revised: 03/25/2011] [Accepted: 04/28/2011] [Indexed: 12/12/2022]
Abstract
Magnetic resonance imaging (MRI) has been used to follow the course of bleomycin-induced lung injury in mice and to investigate two knockout mouse lines with the aim of providing potential therapeutic targets. Bleomycin (0.25 mg/kg) was administered intranasally six times, once a day. MRI was carried out on spontaneously breathing animals up to day 70 after bleomycin. Neither cardiac nor respiratory gating was applied during image acquisition. A long lasting response following bleomycin has been detected by MRI in the lungs of male C57BL/6 mice. Histology showed that, from day 14-70 after bleomycin, fibrosis was the predominant component of the injury. Female C57BL/6 mice displayed a smaller response than males. Bleomycin-induced injury was significantly more pronounced in C57BL/6 than in Balb/C mice. MRI and histology demonstrated a protection against bleomycin insult in female heterozygous and male homozygous cancer Osaka thyroid kinase knockout animals. In contrast, no protection was seen in cadherin-11 knockout animals. In summary, MRI can quantify, in spontaneously breathing mice, bleomycin-induced lung injury. With the ability for repetitive measurements in the same animal, the technique is attractive for in vivo target analysis and compound profiling in this murine model.
Collapse
Affiliation(s)
- Anna L Babin
- Global Imaging Group, Novartis Institutes for BioMedical Research, Basel, Switzerland
| | | | | | | | | | | | | | | |
Collapse
|